Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells

Andrew M. Hau, Sounak Gupta, Mariah Z. Leivo, Kazufumi Nakashima, Jesus Macias, Weidong Zhou, Alex Hodge, Julie Wulfkuhle, Brian Conkright, Krithika Bhuvaneshwar, Shruti Rao, Subha Madhavan, Emanuel F. Petricoin, Donna E. Hansel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

The mammalian target of rapamycin (mTOR) and associated phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway is commonly up-regulated in cancer, including bladder cancer. mTOR complex 2 (mTORC2) is a major regulator of bladder cancer cell migration and invasion, but the mechanisms by which mTORC2 regulates these processes are unclear. A discovery mass spectrometry and reverse-phase protein array–based proteomics dual approach was used to identify novel mTORC2 phosphoprotein targets in actively invading cancer cells. mTORC2 targets included focal adhesion kinase, proto-oncogene tyrosine-protein kinase Src, and caveolin-1 (Cav-1), among others. Functional testing shows that mTORC2 regulates Cav-1 localization and dynamic phosphorylation of Cav-1 on Y14. Regulation of Cav-1 activity by mTORC2 also alters the abundance of caveolae, which are specialized lipid raft invaginations of the plasma membrane associated with cell signaling and membrane compartmentalization. Our results demonstrate a unique role for mTORC2-mediated regulation of caveolae formation in actively migrating cancer cells.

Original languageEnglish
Pages (from-to)1846-1862
Number of pages17
JournalAmerican Journal of Pathology
Volume189
Issue number9
DOIs
StatePublished - Sep 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells'. Together they form a unique fingerprint.

Cite this